New Milestone: Planning to sign a framework agreement for acquisition, intending to indirectly acquire a 65% stake in Taiyuan Zhonghua Second Construction Hospital Co., Ltd.

robot
Abstract generation in progress

Mars Finance News, April 15: Xinli Cheng announced that the company has signed a “Framework Agreement on the Acquisition of Taiyuan Zhonghua Second Construction Hospital Co., Ltd.” with Beijing Xinli Cheng Health Industry Group Co., Ltd., under which the company plans to indirectly acquire 65% of the equity interests in Taiyuan Zhonghua Second Construction Hospital Co., Ltd. The specific acquisition arrangement is as follows: the company’s controlling shareholder, Xinli Cheng Group, and/or an entity controlled by it will establish a limited liability company (SPV). The SPV will first acquire 65% of the equity interest in Taiyuan Second Construction Hospital Co., Ltd. held by Beijing Hongci Medical Investment Management Co., Ltd. The company and/or its subsidiaries will acquire 100% of the SPV’s equity interests and indirectly acquire 65% of the equity interest in Taiyuan Zhonghua Second Construction Hospital Co., Ltd. The Taiyuan Zhonghua Second Construction Hospital Co., Ltd. is the organizer of the Sinochem Second Construction Group Hospital. The hospital’s operating nature will be changed to a for-profit model, and it has obtained approval from the Taiyuan Municipal Health Commission. The “Framework Agreement” signed in this transaction is only a framework agreement for the equity acquisition, representing an intention to cooperate among the parties. The acquisition is still subject to tasks such as audit and assessment, and the signing of a formal equity transfer agreement and the implementation of the transaction must be carried out following necessary decision-making and approval procedures. There are still uncertainties as to whether the final transaction will be completed. (Company Announcement)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin